Evidence map›Paper›PMID 42056216›Full record

ArticleScientific reports2026

A multi-omics study revealed regulatory mechanism landscape of high-altitude congenital heart disease in Tibetan female patients.

Jixuan Xu, Kaisheng Lai, Zhengyao Cai, Hongwei Li, Wen Pan, Qianqiu Che, Mingshuang Zhou, Siyu Wang, Hui Jiang, Yong Wu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jixuan Xu *Department of Biobank, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Kaisheng Lai *Department of Scientific Research Center, BestNovo (Beijing) Medical Technology Co., LTD., Beijing, 102206, China.
Zhengyao Cai *Department of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Hongwei LiDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Wen PanDepartment of Health Management Center, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Qianqiu CheDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Mingshuang ZhouDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Siyu WangDepartment of Biobank, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Hui JiangDepartment of Scientific Research Center, BestNovo (Beijing) Medical Technology Co., LTD., Beijing, 102206, China.
Yong WuDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Lanxin LiuDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Wei DuDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China.
Liming ZhaoDepartment of Cardiovascular, Hospital of Chengdu Office of People's Government of Xizang Autonomous Region (Hospital.C.X.), Chengdu, 610041, Sichuan, China. chichalyzlm@bestnovo.com.ORCID http://orcid.org/0009-0009-3921-4798

Funding

Science and Technology Major Project of Tibetan Autonomous Region of China XZ202201ZD0001G01Science and Technology Plan Project of the Department of Science and Technology of Tibet Autonomous Region XZ202403ZY0006Supported by the Science and Technology Projects of Xizang Autonomous Region, China XZ202402ZY0003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Data-independent acquisition (DIA) proteomicsHigh-altitude congenital heart disease (HA-CHD)Multi-omicsWhole transcriptome sequencing

Identifiers

PMID42056216
PMCPMC13315969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.